Kathy Nixon Speechley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathy Nixon Speechley has a total of 221 co-authors. Here are the top co-authors by number of shared publications:
- Beth K. Potter
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada
9 shared publications Mark A. Ferro
School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada
8 shared publications- Kumanan Wilson
Bruyère Health Research Institute, Bruyère Health, Ottawa, Canada
7 shared publications - Anne-Marie Laberge
Department of Social and Preventive Medicine, School of Public Health University of Montréal Montreal Canada
6 shared publications - Chitra Prasad
Division of Medical Genetics, Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
6 shared publications - Doug Coyle
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada
6 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Feasibility of using Making Mindfulness Matter© for children with epilepsy and their parents: A pilot randomized controlled trial
- 1 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Open AccessFeasibility of using Making Mindfulness Matter© for children with epilepsy and their parents: A pilot randomized controlled trial
- Open Access
- 27 June 2026
- Published by Elsevier in Sleep Medicine
- Vol. 146, 109097
Sleep disturbances in patients with vasculitis
- 27 June 2026
- Published by Elsevier in Sleep Medicine
- Vol. 146, 109097
Open AccessSleep disturbances in patients with vasculitis
- Open Access
- 10 June 2026
- Published by Elsevier in Health Care Transitions
- Vol. 4
An e-health transition intervention for youth with brain-based disabilities: Pilot and feasibility results from a Randomized Controlled Trial
- 10 June 2026
- Published by Elsevier in Health Care Transitions
- Vol. 4
Open AccessAn e-health transition intervention for youth with brain-based disabilities: Pilot and feasibility results from a Randomized Controlled Trial
- Open Access
- 10 June 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional study
Background: Children with inherited metabolic diseases (IMDs) often have high care needs that require extensive involvement of family caregivers. This study aimed to describe caregiver experiences, including management of children’s needs at home, and the impacts of that management on family time, finances, and caregiver and child health-related quality of life (HRQoL). Methods: In this sub-study within a larger cohort study, participants were family caregivers of children ≤ 12 years old diagnosed with an IMD, from across Canada. We collected cross-sectional data using an online questionnaire consisting of validated measures and team-developed questions, and analyzed data descriptively. Results: Seventy-one caregivers participated and reported using a range of supports and interventions to care for their children with IMDs, with dietary supports being most common (77.1%). Twenty-seven participants (45%) reported spending ≥ 4 extra hours per week assisting their child with care supports at home and 28 reported ≥ 6 missed days of work by caregivers in the past year for IMD care. All participants reported fulfillment from caregiving tasks, although 82% reported mental struggles related to caregiving. Based on caregiver reports, children with IMDs had lower HRQoL relative to population normative data. We observed lower median scores for several HRQoL subscales among children with IMDs classified as progressive with multi-system involvement relative to other IMDs. Conclusion: We identified important impacts of IMD care for family caregivers. Relief from high levels of caregiving responsibility and time should be a priority for the development of healthcare policies and interventions, to improve health and well-being for both children and their caregivers.
- 10 June 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
Open AccessThe impacts of caring for children with inherited metabolic diseases for families: a cross-sectional study
Background: Children with inherited metabolic diseases (IMDs) often have high care needs that require extensive involvement of family caregivers. This study aimed to describe caregiver experiences, including management of children’s needs at home, and the impacts of that management on family time, finances, and caregiver and child health-related quality of life (HRQoL). Methods: In this sub-study within a larger cohort study, participants were family caregivers of children ≤ 12 years old diagnosed with an IMD, from across Canada. We collected cross-sectional data using an online questionnaire consisting of validated measures and team-developed questions, and analyzed data descriptively. Results: Seventy-one caregivers participated and reported using a range of supports and interventions to care for their children with IMDs, with dietary supports being most common (77.1%). Twenty-seven participants (45%) reported spending ≥ 4 extra hours per week assisting their child with care supports at home and 28 reported ≥ 6 missed days of work by caregivers in the past year for IMD care. All participants reported fulfillment from caregiving tasks, although 82% reported mental struggles related to caregiving. Based on caregiver reports, children with IMDs had lower HRQoL relative to population normative data. We observed lower median scores for several HRQoL subscales among children with IMDs classified as progressive with multi-system involvement relative to other IMDs. Conclusion: We identified important impacts of IMD care for family caregivers. Relief from high levels of caregiving responsibility and time should be a priority for the development of healthcare policies and interventions, to improve health and well-being for both children and their caregivers.
The association of air pollution with new‐onset epilepsy
Objective: Air pollution has been associated with certain neurological disorders, but its association with epilepsy has been insufficiently explored. The study's objective was to estimate the association of long‐term exposure to fine particulate matter (PM 2.5 ), nitrogen dioxide (NO 2 ), and ozone (O 3 ) with the risk of new‐onset epilepsy among adults in Ontario, Canada. Methods: We used a nested case–control study design and linked health and environmental databases, including Ontario residents ages 18 to 80 as of January 1, 2010, without prior diagnoses of seizures or epilepsy. We identified cases as those who developed epilepsy by December 31, 2016, and matched each with up to five controls on age and sex. We used individual‐ and multi‐pollutant conditional logistic regression models to estimate the associations between interquartile range (IQR) increases in each pollutant and new‐onset epilepsy. Results: We included 24 761 cases and 118 692 controls. The median (IQR) pollutant concentrations were 7.9 (1.3) μg/m 3 for PM 2.5 , 9.6 (9.2) ppb for NO 2 , and 42.7 (5.4) ppb for O 3 . In the individual pollutant models, we observed significant associations with epilepsy for PM 2.5 (incident rate ratio [IRR] = 1.055, 95% confidence interval [CI]: 1.034–1.076), NO 2 (IRR = 0.938, 95% CI: 0.903–0.974), and O 3 (IRR = 1.096, 95% CI: 1.074–1.119). In the multi‐pollutant model, we observed significant associations with epilepsy for NO 2 (IRR = 0.928, 95% CI: 0.891–0.965) and O 3 (IRR = 1.090, 95% CI: 1.060–1.121). Although the association for NO 2 was negative overall, the association was positive among individuals 65 and older. Significance: PM 2.5 and O 3 may be associated with an increased risk of new‐onset epilepsy. We also observed a negative association for NO 2 . However, residual confounding may have occurred. Future research should continue exploring the associations between specific air pollutants and new‐onset epilepsy.
The association of air pollution with new‐onset epilepsy
Objective: Air pollution has been associated with certain neurological disorders, but its association with epilepsy has been insufficiently explored. The study's objective was to estimate the association of long‐term exposure to fine particulate matter (PM 2.5 ), nitrogen dioxide (NO 2 ), and ozone (O 3 ) with the risk of new‐onset epilepsy among adults in Ontario, Canada. Methods: We used a nested case–control study design and linked health and environmental databases, including Ontario residents ages 18 to 80 as of January 1, 2010, without prior diagnoses of seizures or epilepsy. We identified cases as those who developed epilepsy by December 31, 2016, and matched each with up to five controls on age and sex. We used individual‐ and multi‐pollutant conditional logistic regression models to estimate the associations between interquartile range (IQR) increases in each pollutant and new‐onset epilepsy. Results: We included 24 761 cases and 118 692 controls. The median (IQR) pollutant concentrations were 7.9 (1.3) μg/m 3 for PM 2.5 , 9.6 (9.2) ppb for NO 2 , and 42.7 (5.4) ppb for O 3 . In the individual pollutant models, we observed significant associations with epilepsy for PM 2.5 (incident rate ratio [IRR] = 1.055, 95% confidence interval [CI]: 1.034–1.076), NO 2 (IRR = 0.938, 95% CI: 0.903–0.974), and O 3 (IRR = 1.096, 95% CI: 1.074–1.119). In the multi‐pollutant model, we observed significant associations with epilepsy for NO 2 (IRR = 0.928, 95% CI: 0.891–0.965) and O 3 (IRR = 1.090, 95% CI: 1.060–1.121). Although the association for NO 2 was negative overall, the association was positive among individuals 65 and older. Significance: PM 2.5 and O 3 may be associated with an increased risk of new‐onset epilepsy. We also observed a negative association for NO 2 . However, residual confounding may have occurred. Future research should continue exploring the associations between specific air pollutants and new‐onset epilepsy.
Trajectories of parent well‐being in children with drug‐resistant epilepsy
Objective: This longitudinal cohort study aimed to identify trajectories of parent well‐being over the first 2 years after their child's evaluation for candidacy for epilepsy surgery, and to identify the baseline clinical and demographic characteristics associated with these trajectories. Parent well‐being was based on parent depressive and anxiety symptoms and family resources (i.e., family mastery and social support).Methods: Parents of 259 children with drug‐resistant epilepsy (105 of whom eventually had surgery) were recruited from eight epilepsy centers across Canada at the time of their evaluation for epilepsy surgery candidacy. Participants were assessed at baseline and 6‐month, 1‐year, and 2‐year follow‐up. The trajectories of parents' depressive symptoms, anxiety symptoms, and family resources were jointly estimated using multigroup latent class growth models.Results: The analyses identified three trajectories: an optimal‐stable group with no/minimal depressive or anxiety symptoms, and high family resources that remained stable over time; a mild‐decreasing‐plateau group with mild depressive and anxiety symptoms that decreased over time then plateaued, and intermediate family resources that remained stable; and a moderate‐decreasing group with moderate depressive and anxiety symptoms that decreased slightly, and low family resources that remained stable over time. Parents of children with higher health‐related quality of life, fathers, and parents who had higher household income were more likely to have better trajectories of well‐being. Treatment type was not associated with the trajectory groups, but parents whose children were seizure‐free at the time of the last follow‐up were more likely to have better trajectories (optimal‐stable or mild‐decreasing‐plateau trajectories).Significance: This study documented distinct trajectories of parent well‐being, from the time of the child's evaluation for epilepsy surgery. Parents who present with anxiety and depressive symptoms and low family resources do not do well over time. They should be identified and offered supportive services early in their child's epilepsy treatment history.
Trajectories of parent well‐being in children with drug‐resistant epilepsy
Objective: This longitudinal cohort study aimed to identify trajectories of parent well‐being over the first 2 years after their child's evaluation for candidacy for epilepsy surgery, and to identify the baseline clinical and demographic characteristics associated with these trajectories. Parent well‐being was based on parent depressive and anxiety symptoms and family resources (i.e., family mastery and social support).Methods: Parents of 259 children with drug‐resistant epilepsy (105 of whom eventually had surgery) were recruited from eight epilepsy centers across Canada at the time of their evaluation for epilepsy surgery candidacy. Participants were assessed at baseline and 6‐month, 1‐year, and 2‐year follow‐up. The trajectories of parents' depressive symptoms, anxiety symptoms, and family resources were jointly estimated using multigroup latent class growth models.Results: The analyses identified three trajectories: an optimal‐stable group with no/minimal depressive or anxiety symptoms, and high family resources that remained stable over time; a mild‐decreasing‐plateau group with mild depressive and anxiety symptoms that decreased over time then plateaued, and intermediate family resources that remained stable; and a moderate‐decreasing group with moderate depressive and anxiety symptoms that decreased slightly, and low family resources that remained stable over time. Parents of children with higher health‐related quality of life, fathers, and parents who had higher household income were more likely to have better trajectories of well‐being. Treatment type was not associated with the trajectory groups, but parents whose children were seizure‐free at the time of the last follow‐up were more likely to have better trajectories (optimal‐stable or mild‐decreasing‐plateau trajectories).Significance: This study documented distinct trajectories of parent well‐being, from the time of the child's evaluation for epilepsy surgery. Parents who present with anxiety and depressive symptoms and low family resources do not do well over time. They should be identified and offered supportive services early in their child's epilepsy treatment history.
- 2 September 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 111, 196-202
Pre-Operative Predictors of Health-Related Quality of Life Two Years After Pediatric Epilepsy Surgery: A Prospective Cohort Study
- 2 September 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 111, 196-202
Pre-Operative Predictors of Health-Related Quality of Life Two Years After Pediatric Epilepsy Surgery: A Prospective Cohort Study
A longitudinal cohort study of mediators of health‐related quality of life after pediatric epilepsy surgery or medical treatment
Objectives: The purpose of this longitudinal cohort study was to examine the variables that influence health‐related quality of life (HRQOL) after epilepsy surgery in children. We examined whether treatment type (surgical vs medical therapy) and seizure control are related to other variables that have been shown to influence HRQOL, namely depressive symptoms in children with epilepsy or their parents, and the availability of family resources.Methods: In total, 265 children with drug‐resistant epilepsy were recruited from eight epilepsy centers across Canada at the time of their evaluation for candidacy for epilepsy surgery and were assessed at baseline, 6‐month, 1‐year, and 2‐year follow‐up. Parents completed the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE‐55) and measures of family resources and depression; children completed depression inventories. Causal mediation analyses using natural effect models were used to evaluate the extent to which the relationship between treatment and HRQOL was explained by seizure control, child and parent depressive symptoms, and family resources.Results: Overall, 111 children underwent surgery and 154 were treated with medical therapy only. The HRQOL scores of surgical patients were 3.4 points higher (95% confidence interval [CI]: −0.2, 7.0) relative to medical patients at the 2‐year follow‐up after adjusting for baseline covariates, with 66% of the effect of surgery attributed to seizure control. Child or parent depressive symptoms and family resources had negligible mediation effects between treatment and HRQOL. The effect of seizure control on HRQOL was not mediated by child or parent depressive symptoms, or by family resources.Significance: The findings demonstrate that seizure control is on the causal pathway between epilepsy surgery and improved HRQOL in children with drug‐resistant epilepsy. However, child and parent depressive symptoms and family resources were not significant mediators. The results highlight the importance of achieving seizure control to improve HRQOL.
A longitudinal cohort study of mediators of health‐related quality of life after pediatric epilepsy surgery or medical treatment
Objectives: The purpose of this longitudinal cohort study was to examine the variables that influence health‐related quality of life (HRQOL) after epilepsy surgery in children. We examined whether treatment type (surgical vs medical therapy) and seizure control are related to other variables that have been shown to influence HRQOL, namely depressive symptoms in children with epilepsy or their parents, and the availability of family resources.Methods: In total, 265 children with drug‐resistant epilepsy were recruited from eight epilepsy centers across Canada at the time of their evaluation for candidacy for epilepsy surgery and were assessed at baseline, 6‐month, 1‐year, and 2‐year follow‐up. Parents completed the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE‐55) and measures of family resources and depression; children completed depression inventories. Causal mediation analyses using natural effect models were used to evaluate the extent to which the relationship between treatment and HRQOL was explained by seizure control, child and parent depressive symptoms, and family resources.Results: Overall, 111 children underwent surgery and 154 were treated with medical therapy only. The HRQOL scores of surgical patients were 3.4 points higher (95% confidence interval [CI]: −0.2, 7.0) relative to medical patients at the 2‐year follow‐up after adjusting for baseline covariates, with 66% of the effect of surgery attributed to seizure control. Child or parent depressive symptoms and family resources had negligible mediation effects between treatment and HRQOL. The effect of seizure control on HRQOL was not mediated by child or parent depressive symptoms, or by family resources.Significance: The findings demonstrate that seizure control is on the causal pathway between epilepsy surgery and improved HRQOL in children with drug‐resistant epilepsy. However, child and parent depressive symptoms and family resources were not significant mediators. The results highlight the importance of achieving seizure control to improve HRQOL.
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Using community-university partnerships to implement WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) 2022-2031: an example focusing on mental health in children with epilepsy and their parents
Background/Objective: In 2022, WHO’s Member States approved The Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP), endorsing a comprehensive, coordinated, intersectoral response to reduce gaps in epilepsy knowledge and treatment. Given the importance of IGAP...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessUsing community-university partnerships to implement WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) 2022-2031: an example focusing on mental health in children with epilepsy and their parents
Background/Objective: In 2022, WHO’s Member States approved The Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP), endorsing a comprehensive, coordinated, intersectoral response to reduce gaps in epilepsy knowledge and treatment. Given the importance of IGAP...
- 15 October 2021
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 22 (2) , 228-243
Initial validation of the global assessment of severity of illness
- 15 October 2021
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 22 (2) , 228-243
Initial validation of the global assessment of severity of illness